Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Get the latest updates from Google Alert - evommune directly as they happen.
Follow now 114 followers
Last updated 5 days ago
6 days ago
Small molecule therapy(Evommune/Accutar Biotechnology)是由Evommune Inc和冰洲石生物科技研发的一种小分子药物,目前该药物最高研发阶段为临床前, ...
6 days ago
Thank you to Evommune for sponsoring our Allen Discovery Center-Cell Symposia. Early...
11 days ago
Evommune is different. We strive to develop accessible innovations that are meant...
17 days ago
Evommune, Inc. is a private clinical-stage biotechnology company dedicated to revolutionizing the...
20 days ago
Evommune raised $81799952 on 2025-01-07 in Venture Round.
23 days ago
Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel...
30 days ago
... Evommune for giving me the opportunity to step into an executive...
about 1 month ago
2025年5月28日,美国Evommune公司公布该靶点临床2a积极结果,在安全性和药效上均达到慢性荨麻疹治疗的主要治疗终点。 与EVO-756相比,AM-001具有潜在更大的安全窗口 ...
about 1 month ago
2025年5月28日,美国Evommune 公司公布该靶点临床2a积极结果,在安全性和药效上均达到慢性荨麻疹治疗的主要治疗终点。临床上一天口服一次300mg或者一天口服两次 ...
about 1 month ago
Evommune今日公布其潜在“first-in-class”在研小分子EVO756在成人慢性诱导性荨麻疹(CIndU)患者中的2期试验积极顶线数据。该数据支持EVO756在CIndU和特应性 ...
about 1 month ago
Plus, news about Immunic, Neurocrine Biosciences, Alcon, AusperBio and Evommune: Taysha Gene...
about 1 month ago
Evommune is proud to announce that Lorena Riol-Blanco, our Vice President, Biology...